Senthil Kumaran Satyanarayanan , Zixu Han , Jingwei Xiao , Qiuju Yuan , Wing Ho Yung , Ya Ke , Raymond Chuen-Chung Chang , Maria Huachen Zhu , Huanxing Su , Kuan-Pin Su , Dajiang Qin , Suki Man Yan Lee
{"title":"神经变性疾病治疗的前沿:瞄准大脑边界区域的免疫细胞。","authors":"Senthil Kumaran Satyanarayanan , Zixu Han , Jingwei Xiao , Qiuju Yuan , Wing Ho Yung , Ya Ke , Raymond Chuen-Chung Chang , Maria Huachen Zhu , Huanxing Su , Kuan-Pin Su , Dajiang Qin , Suki Man Yan Lee","doi":"10.1016/j.bbi.2024.10.007","DOIUrl":null,"url":null,"abstract":"<div><div>Neurodegenerative diseases (NDs) demonstrate a complex interaction with the immune system, challenging the traditional view of the brain as an “immune-privileged” organ. Microglia were once considered the sole guardians of the brain’s immune response. However, recent research has revealed the critical role of peripheral immune cells located in key brain regions like the meninges, choroid plexus, and perivascular spaces. These previously overlooked cells are now recognized as contributors to the development and progression of NDs. This newfound understanding opens doors for pioneering therapeutic strategies. By targeting these peripheral immune cells, we may be able to modulate the brain’s immune environment, offering an alternative approach to treat NDs and circumvent the challenges posed by the blood–brain barrier. This comprehensive review will scrutinize the latest findings on the complex interactions between these peripheral immune cells and NDs. It will also critically assess the prospects of targeting these cells as a ground-breaking therapeutic avenue for these debilitating disorders.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"123 ","pages":"Pages 483-499"},"PeriodicalIF":8.8000,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions\",\"authors\":\"Senthil Kumaran Satyanarayanan , Zixu Han , Jingwei Xiao , Qiuju Yuan , Wing Ho Yung , Ya Ke , Raymond Chuen-Chung Chang , Maria Huachen Zhu , Huanxing Su , Kuan-Pin Su , Dajiang Qin , Suki Man Yan Lee\",\"doi\":\"10.1016/j.bbi.2024.10.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Neurodegenerative diseases (NDs) demonstrate a complex interaction with the immune system, challenging the traditional view of the brain as an “immune-privileged” organ. Microglia were once considered the sole guardians of the brain’s immune response. However, recent research has revealed the critical role of peripheral immune cells located in key brain regions like the meninges, choroid plexus, and perivascular spaces. These previously overlooked cells are now recognized as contributors to the development and progression of NDs. This newfound understanding opens doors for pioneering therapeutic strategies. By targeting these peripheral immune cells, we may be able to modulate the brain’s immune environment, offering an alternative approach to treat NDs and circumvent the challenges posed by the blood–brain barrier. This comprehensive review will scrutinize the latest findings on the complex interactions between these peripheral immune cells and NDs. It will also critically assess the prospects of targeting these cells as a ground-breaking therapeutic avenue for these debilitating disorders.</div></div>\",\"PeriodicalId\":9199,\"journal\":{\"name\":\"Brain, Behavior, and Immunity\",\"volume\":\"123 \",\"pages\":\"Pages 483-499\"},\"PeriodicalIF\":8.8000,\"publicationDate\":\"2024-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain, Behavior, and Immunity\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0889159124006470\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain, Behavior, and Immunity","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0889159124006470","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions
Neurodegenerative diseases (NDs) demonstrate a complex interaction with the immune system, challenging the traditional view of the brain as an “immune-privileged” organ. Microglia were once considered the sole guardians of the brain’s immune response. However, recent research has revealed the critical role of peripheral immune cells located in key brain regions like the meninges, choroid plexus, and perivascular spaces. These previously overlooked cells are now recognized as contributors to the development and progression of NDs. This newfound understanding opens doors for pioneering therapeutic strategies. By targeting these peripheral immune cells, we may be able to modulate the brain’s immune environment, offering an alternative approach to treat NDs and circumvent the challenges posed by the blood–brain barrier. This comprehensive review will scrutinize the latest findings on the complex interactions between these peripheral immune cells and NDs. It will also critically assess the prospects of targeting these cells as a ground-breaking therapeutic avenue for these debilitating disorders.
期刊介绍:
Established in 1987, Brain, Behavior, and Immunity proudly serves as the official journal of the Psychoneuroimmunology Research Society (PNIRS). This pioneering journal is dedicated to publishing peer-reviewed basic, experimental, and clinical studies that explore the intricate interactions among behavioral, neural, endocrine, and immune systems in both humans and animals.
As an international and interdisciplinary platform, Brain, Behavior, and Immunity focuses on original research spanning neuroscience, immunology, integrative physiology, behavioral biology, psychiatry, psychology, and clinical medicine. The journal is inclusive of research conducted at various levels, including molecular, cellular, social, and whole organism perspectives. With a commitment to efficiency, the journal facilitates online submission and review, ensuring timely publication of experimental results. Manuscripts typically undergo peer review and are returned to authors within 30 days of submission. It's worth noting that Brain, Behavior, and Immunity, published eight times a year, does not impose submission fees or page charges, fostering an open and accessible platform for scientific discourse.